Photo of Janeen Sollman
D Oregon Senate · District 15

Sen. Janeen Sollman

Compare
Total votes
6,351
all sessions
Attendance
99%
52 missed
Near the chamber average
With party
98%
of cast votes
Near the chamber average
Bipartisan score
1%
crosses aisle rarely
Near the chamber average
Sponsored
902
bills & resolutions
Higher than 83% of chamber peers
Committees
5
assignments
902 bills and resolutions

Sponsored bills

Total
902
Primary
216
Co-sponsor
686
This page
902
matching current filters
Co-sponsor HB 3056
In committee · Oregon House · Co-sponsor
Relating to administrative procedure.

Requires agencies to adopt rules specifying time period during which agency will approve or deny application for license after applicant has amended or modified original application.

In committee Jul 1, 2019 1 co-sponsor
Co-sponsor SB 872
In committee · Oregon Senate · Co-sponsor
Relating to the cost of prescription drugs.

Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total cost of ] amount of money spent on patient assistance programs , and ] information on financial assistance provided to pharmacies, government agencies and advocacy organizations and total amount of financial incentives paid to each pharmacy benefit manager . Excludes proprietary information from disclosure on department's website. ] Exempts from public disclosure information reported to department until department posts to website all information reported by manufacturer. Requires state-sponsored programs that use pharmacy benefit managers to use fee-only pharmacy benefit managers. Requires insurers to post specified information regarding formulary, tiers and costs for small employer and individual health benefit plans to insurer's website. Requires 60-day advance notice to department and to enrollees adversely affected by change in formulary. Requires insurer and allows pharmacy to notify insured that if cash ] retail price for drug is less than insured's cost-share ] out-of-pocket cost for drug using pharmacy benefit , insured may pay cash ] retail price and expense must be counted ] if requested by enrollee, insurer must count cost toward deductible or out-of-pocket maximum. Requires State Board of Pharmacy to prescribe by rule notice of enrollee's rights for distribution to pharmacy customers and to translate notice into multiple languages. Requires hospitals and other medical providers to disclose in patient billing information regarding mark-up on price of drug. Also requires billing to disclose price of drug charged to specified state agencies and insurers ] report to Oregon Health Authority information regarding 50 most prescribed drugs and 50 most expensive drugs prescribed by provider . Requires specified state agencies to report to Legislative Assembly on high-cost drugs. Requires Oregon Health Authority to refer to Pharmacy and Therapeutics Committee any drug exceeding specified cost. Requires patient advocacy organization with budget ] annual gross receipts exceeding $50,000 that has registered lobbyist in this state to report to Oregon Government Ethics Commission and Oregon Health Authority ] specified information regarding funding received from participants in pharmaceutical supply chain. Requires pharmacy benefit managers to report to Department of Consumer and Business Services and plan sponsors specified information regarding rebates, reimbursements, fees and incentives paid for drugs by manufacturers, insurers and pharmacies. Requires insurers to include with rate filing certified statement regarding insurers' use of rebates. Requires drug advertisement to disclose wholesale price of drug. ] Modifies responsibilities of Task Force on Fair Pricing of Prescription Drugs and requires report of findings, by September 15, 2020, to interim committees of Legislative Assembly related to health. Modifies reporting to department by insurers about costly drugs reimbursed by health benefit plans. Requires pharmaceutical manufacturers that register with State Board of Pharmacy to also register with department. Requires department to adopt registration fee based on reasonable cost to department to administer specified provisions.

In committee Jun 30, 2019 1 co-sponsor
Co-sponsor SB 321
Signed into law · Oregon Senate · Co-sponsor
Relating to post-conviction DNA testing.

Modifies procedures by which person convicted of felony initiates proceedings to obtain DNA testing. Directs State Court Administrator to develop forms for use during court proceedings on DNA test requests. Authorizes person requesting testing to file motion requesting property and evidence control and disposition records and other written materials relating to prior forensic testing. Modifies requirements of motion and accompanying documents for DNA testing. Requires person to serve district attorney with copy of all prior sworn statements of person concerning underlying prosecution. Modifies findings that, if made by court, require court to order DNA testing. Establishes findings that, if made by court, authorize court to order DNA testing. Creates procedures by which party seeking testing at certain laboratories may request court to order evaluation of laboratory in order for resulting DNA profile to be eligible for entry into state or national DNA index system. Provides that upon request to district attorney, victim has right to receive notice concerning DNA testing proceedings. Specifies when district attorneys must or may provide notification to crime victims.

Signed into law Jun 21, 2019 1 co-sponsor
Co-sponsor SB 829
Signed into law · Oregon Senate · Co-sponsor
Relating to wine labeling; and prescribing an effective date.

Requires that, to extent provided by Oregon Liquor Control Commission rules, if appellation of origin on wine label is American viticultural area in Oregon that is in larger American viticultural area, label must also identify larger American viticultural area. Requires commission to make requirement applicable by rule within Willamette Valley viticultural area. Prohibits use of American viticultural area on wine label in manner resembling brand. Creates exception. Applies to wine labeled on or after January 1, 2023. Requires commission to appoint advisory committee. Sunsets advisory committee January 2, 2024. Requires commission to adopt rules establishing penalty schedule for labeling requirement. Requires adoption of initial rules in time to take effect January 1, 2023. Repeals rule adoption requirement January 2, 2024. Requires commission to report to interim committee of Legislative Assembly no later than September 15, 2020, regarding advisory committee recommendations and status of commission rule adoption proceedings. Takes effect on 91st day following adjournment sine die.

Signed into law Jun 21, 2019 1 co-sponsor
Co-sponsor SB 638
Signed into law · Oregon Senate · Co-sponsor
Relating to the adoption of research animals.

Requires research facilities that use dogs or cats for laboratory research to offer dogs or cats no longer used for research for adoption prior to euthanasia. Provides that research facility is immune from civil liability for or resulting from transfer of dog or cat, if research facility acted in good faith concerning health and physical condition of dog or cat. Requires certain research facilities to submit annual report to Secretary of State that provides certain information regarding release of dogs and cats and animal shelters with which facilities have entered into written agreements. Provides that reports are confidential and exempt from disclosure except that Secretary of State shall make aggregate data available to public upon request.

Signed into law Jun 21, 2019 1 co-sponsor
Showing 711 to 720 of 902 bills
Previous 1 71 72 73 91 Next